PharmaGiant.com Expands Access to Affordable Medications; Announces Upcoming Generic Semaglutide

WINNIPEG, MB, Feb. 27, 2026 /PRNewswire/ - As prescription drug costs climb in the United States, PharmaGiant.com, a premier prescription referral service, is proud to announce an expansion of its generic medication catalog. A key highlight is the upcoming availability of generic Semaglutide, expected to enter the Canadian market in 2026. This offers a low-cost alternative to expensive brand-name GLP-1 therapies.

PharmaGiant.com bridges the affordability gap by connecting U.S. patients with licensed Canadian pharmacies, where regulated pricing ensures accessibility. The introduction of generic Semaglutide marks a turning point for patients managing Type 2 diabetes and weight health, with expected savings of 60–70% compared to branded versions in the U.S. market.

Real Savings: Brand Name vs. Canadian Generics

U.S. patients often face massive price disparities for maintenance drugs. For example, Eliquis (Apixaban) can cost over $550 for a 30-day supply in the U.S., but PharmaGiant.com offers the generic equivalent starting at just $89. Other notable savings include:

• Rosuvastatin 5mg (30 tablets): $30 at PharmaGiant vs. $136 U.S. retail.
• Amlodipine 5mg (100 tablets): $58.95 at PharmaGiant vs. $117.14 U.S. retail.
• Atorvastatin 10mg (90 tablets): $24 at PharmaGiant vs. $271 U.S. retail.
• Metformin 500mg (100 tablets): $13.99 at PharmaGiant vs. $33 U.S. retail.
• Sertraline 50mg (100 tablets): $59.99 at PharmaGiant vs. $119 U.S. retail.

Maximize Savings with 90-Day Bulk Orders

PharmaGiant.com encourages patients to utilize 90-day bulk ordering to ensure continuity of care while reducing per-unit costs and shipping expenses. All medications are shipped in temperature-controlled, medical-grade packaging to maintain product integrity.

Limited Time Offer for New Customers

To assist those seeking relief from high pharmacy bills, new customers can use coupon code PGSAVE10 at checkout to receive 10% off their first order.

"Our mission is to ensure no one has to choose between their health and financial stability," said a PharmaGiant.com spokesperson. "The arrival of generic Semaglutide reinforces our commitment to safe, affordable, and transparent healthcare options."

For more information, please visit www.pharmagiant.com.

PharmaGiant.com

View original content:https://www.prnewswire.com/news-releases/pharmagiantcom-expands-access-to-affordable-medications-announces-upcoming-generic-semaglutide-302699684.html

SOURCE PharmaGiant.com